We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$5.39B
AUM Growth
-$596M
Cap. Flow
-$835M
Cap. Flow %
-15.48%
Top 10 Hldgs %
14.54%
Holding
365
New
12
Increased
84
Reduced
214
Closed
25

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$72.5M
2
STE icon
Steris
STE
+$42.9M
3
MDT icon
Medtronic
MDT
+$38.2M
4
SWI
SOLARWINDS INC COM STK (DE)
SWI
+$32.9M
5
FLO icon
Flowers Foods
FLO
+$32.9M

Sector Composition

Rank Sector Weight
1 Financials 18.5%
2 Healthcare 15.85%
3 Technology 14.25%
4 Industrials 12.91%
5 Consumer Discretionary 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$364B
$46.8M 0.87%
1,281,873
+18,918
+1% +$722K
PG icon
27
Procter & Gamble
PG
$349B
$45.7M 0.85%
575,005
-128,283
-18% -$9.8M
MTD icon
28
Mettler-Toledo International
MTD
$26.5B
$42.9M 0.8%
126,417
-2,496
-2% -$801K
USB icon
29
US Bancorp
USB
$98.4B
$42.1M 0.78%
986,937
+64,686
+7% +$2.76M
UPS icon
30
United Parcel Service
UPS
$100B
$41.2M 0.76%
428,375
+480
+0.1% +$49K
BOH icon
31
Bank of Hawaii
BOH
$3.4B
$41M 0.76%
652,522
-238,380
-27% -$15.6M
OGS icon
32
ONE Gas
OGS
$5B
$40.1M 0.74%
798,824
-249,333
-24% -$12M
SYK icon
33
Stryker
SYK
$123B
$39.6M 0.73%
425,623
-1,569
-0.4% -$150K
CL icon
34
Colgate-Palmolive
CL
$74.4B
$38.1M 0.71%
571,951
-53,123
-8% -$3.53M
COR
35
DELISTED
Coresite Realty Corporation
COR
$37.4M 0.69%
659,303
-172,511
-21% -$9.77M
SYNT
36
DELISTED
Syntel Inc
SYNT
$36.7M 0.68%
811,374
-219,803
-21% -$10.3M
UNP icon
37
Union Pacific
UNP
$179B
$35.4M 0.66%
452,281
+19,990
+5% +$1.72M
IPGP icon
38
IPG Photonics
IPGP
$4.43B
$35M 0.65%
392,744
-99,100
-20% -$8.49M
UNF icon
39
Unifirst Corp
UNF
$5.27B
$34.7M 0.64%
332,621
-108,086
-25% -$11.5M
CBSH icon
40
Commerce Bancshares
CBSH
$8.51B
$34.4M 0.64%
1,318,865
-387,860
-23% -$10.5M
XRAY icon
41
Dentsply Sirona
XRAY
$2.81B
$34.1M 0.63%
560,490
-8,115
-1% -$483K
HUBB icon
42
Hubbell
HUBB
$25.8B
$32.4M 0.6%
+320,917
New +$32.8M
SKT icon
43
Tanger
SKT
$4.8B
$31.7M 0.59%
969,424
-148,183
-13% -$5.03M
AXP icon
44
American Express
AXP
$242B
$31.6M 0.59%
453,865
-26,785
-6% -$1.95M
LECO icon
45
Lincoln Electric
LECO
$13.8B
$31.3M 0.58%
602,549
+196,889
+49% +$11M
POLY
46
DELISTED
Plantronics, Inc.
POLY
$30.3M 0.56%
638,563
-193,407
-23% -$10M
ACH
47
Accendra Health
ACH
$266M
$30.2M 0.56%
839,197
-115,074
-12% -$4.16M
COP icon
48
ConocoPhillips
COP
$140B
$29.9M 0.55%
639,642
-34,663
-5% -$1.81M
WAT icon
49
Waters Corp
WAT
$36.2B
$29.6M 0.55%
219,838
-6,290
-3% -$808K
AAP icon
50
Advance Auto Parts
AAP
$3.21B
$29.5M 0.55%
196,221
+176
+0.1% +$30.6K

Similar funds

Boston Trust Walden's Q4 2015 Portfolio in Review

As of Q4 2015, Boston Trust Walden held 365 positions worth $5.39B, down 9.9% from $5.99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Trust Walden withdrew a net $835M in Q4 2015, closing 25 positions and reducing 214 holdings. Its most notable exit was Accenture, an estimated $72.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boston Trust Walden opened a new position in Hubbell worth $32.4M.

  • Boston Trust Walden's largest Q4 2015 buy was Hubbell: 320,917 shares worth $32.4M.
  • Boston Trust Walden added most to Sally Beauty Holdings in Q4 2015, an estimated $23.7M increase.
  • Boston Trust Walden's biggest Q4 2015 reduction was Flowers Foods, cutting an estimated $32.9M.
  • Boston Trust Walden fully exited Accenture in Q4 2015, selling an estimated $72.5M.
  • Boston Trust Walden's ten largest holdings make up 15% of its $5.39B portfolio in Q4 2015.
  • Boston Trust Walden opened 12 new positions and closed 25 in Q4 2015.
  • Boston Trust Walden's portfolio value fell 9.9% quarter-over-quarter to $5.39B.

Based on Boston Trust Walden's 13F filing for Q4 2015, filed 21 Jan 2016.